Previous studies of GBM using single omics have pinpointed molecular anomalies such as IDH1, TP53, PTEN, EGFR, and PIK3CA, impacting tumour progression and survival prognosis.31, 32, 93, 94, 95, 96. The gene discussed is IDH1; the disease is neoplasm.